MeTA is an alliance of partners working to improve access to medicines by increasing transparency and accountability in the healthcare market. Bringing together stakeholders in the pharmaceutical sector at both national and international level, MeTA is looking at ways to improve information flows and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. Seven countries took part in the pilot stage:
In each of these countries a MeTA council has been formed, made up of representatives from government, civil society and the private sector. This council meets to discuss how to disclose information under the MeTA programme and what should be done with that information to improve the decisions of policy makers.
Countries can access support from the Technical Director, short-term technical assistance from consultants, as well as up to £100,000 of funds per year for implementation of the project.
How to apply:
Currently there is no funding available. Details available on the Medicines Transparency Alliance (MeTA) website